• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EVI1 调控的 GPR56 维持骨髓龛中的造血干细胞池。

Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56.

机构信息

Division of Tumor and Cellular Biochemistry, Department of Medical Science, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

出版信息

Leukemia. 2013 Aug;27(8):1637-49. doi: 10.1038/leu.2013.75. Epub 2013 Mar 12.

DOI:10.1038/leu.2013.75
PMID:23478665
Abstract

Acute myeloid leukemia with high ecotropic viral integration site-1 expression (EVI1(high) AML) is classified as a refractory type of leukemia with a poor prognosis. To provide new insights into the prevention and treatment of this disease, we identified the high expression of EVI1-regulated G protein-coupled receptor 56 (GPR56), and the association of high cell adhesion and antiapoptotic activities in EVI1(high) AML cells. Knockdown of GPR56 expression decreased the cellular adhesion ability through inactivation of RhoA signaling, resulting in a reduction of cellular growth rates and enhanced apoptosis. Moreover, in Gpr56(-/-) mice, the number of hematopoietic stem cells (HSCs) was significantly decreased in the bone marrow (BM) and, conversely, was increased in the spleen, liver and peripheral blood. The number of Gpr56(-/-) HSC progenitors in the G0/G1-phase was significantly reduced and was associated with impaired cellular adhesion. Finally, the loss of GPR56 function resulted in a reduction of the in vivo repopulating ability of the HSCs. In conclusion, GPR56 may represent an important GPCR for the maintenance of HSCs by acting as a co-ordinator of interactions with the BM osteosteal niche; furthermore, this receptor has the potential to become a novel molecular target in EVI1(high) leukemia.

摘要

高表达嗜酸性病毒整合位点 1 的急性髓系白血病(EVI1(high) AML)被归类为难治性白血病,预后不良。为了深入了解这种疾病的预防和治疗,我们发现 EVI1 调控的 G 蛋白偶联受体 56(GPR56)在 EVI1(high) AML 细胞中高表达,并与高细胞黏附和抗凋亡活性相关。GPR56 表达的敲低通过失活 RhoA 信号降低了细胞黏附能力,导致细胞生长速率降低和凋亡增强。此外,在 Gpr56(-/-) 小鼠中,骨髓中的造血干细胞(HSCs)数量显著减少,而脾脏、肝脏和外周血中的 HSCs 数量则增加。Gpr56(-/-) HSC 祖细胞在 G0/G1 期的数量明显减少,与细胞黏附受损有关。最后,GPR56 功能的丧失导致 HSCs 的体内重编程能力降低。总之,GPR56 可能通过作为与 BM 成骨龛相互作用的协调因子,代表维持 HSCs 的重要 GPCR;此外,该受体有可能成为 EVI1(high) 白血病的新分子靶点。

相似文献

1
Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56.EVI1 调控的 GPR56 维持骨髓龛中的造血干细胞池。
Leukemia. 2013 Aug;27(8):1637-49. doi: 10.1038/leu.2013.75. Epub 2013 Mar 12.
2
[Maintenance of leukemic and normal hematopoietic stem cells in bone marrow niches by EVI1-regulated GPR56].[EVI1调控的GPR56维持白血病和正常造血干细胞在骨髓龛中的状态]
Rinsho Ketsueki. 2015 Apr;56(4):375-83. doi: 10.11406/rinketsu.56.375.
3
Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells.血管生成素 1 有助于 EVI1(high) 白血病细胞的静止状态维持。
Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):239-45. doi: 10.1016/j.bbrc.2011.10.061. Epub 2011 Oct 18.
4
Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression.吡咯并咪唑聚酰胺抑制 GPR56 表达为高 EVI1 表达的 AML 提供了一种新的治疗药物。
Sci Rep. 2018 Sep 13;8(1):13741. doi: 10.1038/s41598-018-32205-8.
5
Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression.致癌转录因子Evi1通过GATA-2的表达来调节造血干细胞的增殖。
EMBO J. 2005 Jun 1;24(11):1976-87. doi: 10.1038/sj.emboj.7600679. Epub 2005 May 12.
6
The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.整合素 α6(ITGA6)表达增加增强了 EVI1(高)白血病的耐药性。
PLoS One. 2012;7(1):e30706. doi: 10.1371/journal.pone.0030706. Epub 2012 Jan 25.
7
Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis.嗜同性病毒整合位点 1、干细胞自我更新与白血病发生。
Cancer Sci. 2012 Aug;103(8):1371-7. doi: 10.1111/j.1349-7006.2012.02303.x. Epub 2012 May 18.
8
The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.MDS 和 EVI1 复合物基因座(MECOM)异构体调节自身转录,在造血干细胞和祖细胞的转化中具有不同的作用。
Biochim Biophys Acta Gene Regul Mech. 2017 Jun;1860(6):721-729. doi: 10.1016/j.bbagrm.2017.03.007. Epub 2017 Apr 6.
9
Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia.化疗药物诱导促凋亡肿瘤抑制基因细胞黏附分子1的表达在耐药急性髓系白血病中受到抑制。
Mol Carcinog. 2015 Dec;54(12):1815-9. doi: 10.1002/mc.22252. Epub 2014 Dec 9.
10
Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity.Evi1 对于造血干细胞自我更新是必需的,其表达标志着具有长期多谱系重建造血活性的造血细胞。
J Exp Med. 2011 Nov 21;208(12):2403-16. doi: 10.1084/jem.20110447. Epub 2011 Nov 14.

引用本文的文献

1
Exploring the contribution of Zfp521/ZNF521 on primary hematopoietic stem/progenitor cells and leukemia progression.探索Zfp521/ZNF521对原发性造血干细胞/祖细胞及白血病进展的作用。
Cell Tissue Res. 2024 Dec;398(3):161-173. doi: 10.1007/s00441-024-03926-2. Epub 2024 Oct 22.
2
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study.LSC17 评分可补充急性髓系白血病的遗传学和可测量残留病:一项 ALFA 研究。
Blood Adv. 2023 Aug 8;7(15):4024-4034. doi: 10.1182/bloodadvances.2023010155.
3
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets.
癌症代谢中的信号通路:机制和治疗靶点。
Signal Transduct Target Ther. 2023 May 10;8(1):196. doi: 10.1038/s41392-023-01442-3.
4
Mecom mutation related to radioulnar synostosis with amegakaryocytic thrombocytopenia reduces HSPCs in mice.Mecom 突变与桡尺骨融合伴巨核细胞血小板减少症有关,导致小鼠 HSPC 减少。
Blood Adv. 2023 Sep 26;7(18):5409-5420. doi: 10.1182/bloodadvances.2022008462.
5
Role of Adhesion G Protein-Coupled Receptors in Immune Dysfunction and Disorder.黏附 G 蛋白偶联受体在免疫功能障碍和疾病中的作用。
Int J Mol Sci. 2023 Mar 13;24(6):5499. doi: 10.3390/ijms24065499.
6
Cell competition in development, homeostasis and cancer.发育、体内平衡和癌症中的细胞竞争
Nat Rev Mol Cell Biol. 2023 Mar;24(3):221-236. doi: 10.1038/s41580-022-00538-y. Epub 2022 Sep 29.
7
Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology.黏附 G 蛋白偶联受体:结构、信号转导、生理学和病理生理学。
Physiol Rev. 2022 Oct 1;102(4):1587-1624. doi: 10.1152/physrev.00027.2021. Epub 2022 Apr 25.
8
Role of ADGRG1/GPR56 in Tumor Progression.ADGRG1/GPR56 在肿瘤进展中的作用。
Cells. 2021 Nov 29;10(12):3352. doi: 10.3390/cells10123352.
9
The role of GPR56/ADGRG1 in health and disease.GPR56/ADGRG1 在健康和疾病中的作用。
Biomed J. 2021 Oct;44(5):534-547. doi: 10.1016/j.bj.2021.04.012. Epub 2021 May 4.
10
Crucial contribution of GPR56/ADGRG1, expressed by breast cancer cells, to bone metastasis formation.GPR56/ADGRG1(由乳腺癌细胞表达)对骨转移形成的关键贡献。
Cancer Sci. 2021 Dec;112(12):4883-4893. doi: 10.1111/cas.15150. Epub 2021 Oct 20.